Abstract
Amiodarone can induce TdP; therefore, it should be avoided as a first choice for therapy in patients without heart disease. Careful QT interval monitoring, especially during intravenous use, can prevent development of this life-threatening arrhythmia.
Author supplied keywords
Cite
CITATION STYLE
APA
Nordkin, I., Levinas, T., Rosenfeld, I., & Halabi, M. (2021). Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation. Clinical Case Reports, 9(1), 391–394. https://doi.org/10.1002/ccr3.3539
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free